Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01100424 · ClinicalTrials.gov registry record · NA
Assessment of Tear Film-Based Proteins Associated With Care Solution Induced Corneal Staining
A NA study of Corneal Staining, sponsored by Alcon Research.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT01100424: Completed NA study of Corneal Staining, sponsored by Alcon Research.
NCT01100424 is a NA study of Corneal Staining that has completed, run by Alcon Research. The registered enrollment target is 60 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01100424, a NA study of Corneal Staining, has completed, sponsored by Alcon Research.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study was to investigate the association of inflammatory mediators found in the tear film during the development and following the induction of contact lens solution-induced corneal staining.
Conditions Studied
Interventions
- DEVICE Opti-Free RepleniSH
- DEVICE ReNu MultiPlus
- DEVICE Balafilcon A
- OTHER Unisol 4
Study Locations (1)
Texas
- Contact Alcon Call Center for Trial Locations - Fort Worth
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2010-03 |
| Est. Completion | 2010-09 |
| Phase | NA |
What the finished NCT01100424 record still lists
NCT01100424 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Corneal Staining appearing as the primary indexed condition, and to 4 interventions - of which Opti-Free RepleniSH is the first listed.
NCT01100424 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT01100424 about?
NCT01100424 is a clinical study titled "Assessment of Tear Film-Based Proteins Associated With Care Solution Induced Corneal Staining". The purpose of this study was to investigate the association of inflammatory mediators found in the tear film during the development and following the induction of contact lens solution-induced corneal staining.
What is the current status of trial NCT01100424?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2010-03. Estimated completion is 2010-09.
What conditions does trial NCT01100424 study?
This clinical trial studies the following conditions: Corneal Staining.
What interventions are being tested in trial NCT01100424?
The interventions under investigation include: Opti-Free RepleniSH (DEVICE), ReNu MultiPlus (DEVICE), Balafilcon A (DEVICE), Unisol 4 (OTHER).
Who is sponsoring clinical trial NCT01100424?
This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01100424 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01100424's enrollment target sits among peer trials
60 1164th of 2000 higher than 745 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia